These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 17066390)
1. The importance of the active site histidine for the activity of epoxide- or aziridine-based inhibitors of cysteine proteases. Mladenovic M; Schirmeister T; Thiel S; Thiel W; Engels B ChemMedChem; 2007 Jan; 2(1):120-8. PubMed ID: 17066390 [TBL] [Abstract][Full Text] [Related]
2. Atomistic insights into the inhibition of cysteine proteases: first QM/MM calculations clarifying the regiospecificity and the inhibition potency of epoxide- and aziridine-based inhibitors. Mladenovic M; Junold K; Fink RF; Thiel W; Schirmeister T; Engels B J Phys Chem B; 2008 May; 112(17):5458-69. PubMed ID: 18393547 [TBL] [Abstract][Full Text] [Related]
3. Rational design of improved aziridine-based inhibitors of cysteine proteases. Buback V; Mladenovic M; Engels B; Schirmeister T J Phys Chem B; 2009 Apr; 113(15):5282-9. PubMed ID: 19301885 [TBL] [Abstract][Full Text] [Related]
4. New peptidic cysteine protease inhibitors derived from the electrophilic alpha-amino acid aziridine-2,3-dicarboxylic acid. Schirmeister T J Med Chem; 1999 Feb; 42(4):560-72. PubMed ID: 10052963 [TBL] [Abstract][Full Text] [Related]
5. Theoretical studies about the influence of different ring substituents on the nucleophilic ring opening of three-membered heterocycles and possible implications for the mechanisms of cysteine protease inhibitors. Helten H; Schirmeister T; Engels B J Org Chem; 2005 Jan; 70(1):233-7. PubMed ID: 15624927 [TBL] [Abstract][Full Text] [Related]
6. Atomistic insights into the inhibition of cysteine proteases: first QM/MM calculations clarifying the stereoselectivity of epoxide-based inhibitors. Mladenovic M; Ansorg K; Fink RF; Thiel W; Schirmeister T; Engels B J Phys Chem B; 2008 Sep; 112(37):11798-808. PubMed ID: 18712902 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of cysteine proteases by peptides containing aziridine-2,3-dicarboxylic acid building blocks. Schirmeister T Biopolymers; 1999; 51(1):87-97. PubMed ID: 10380356 [TBL] [Abstract][Full Text] [Related]
8. Rapid kinetic studies and structural determination of a cysteine proteinase mutant imply that residue 158 in caricain has a major effect upon the ability of the active site histidine to protonate a dipyridyl probe. Katerelos NA; Goodenough PW Biochemistry; 1996 Nov; 35(47):14763-72. PubMed ID: 8942638 [TBL] [Abstract][Full Text] [Related]
9. Rational design of aziridine-containing cysteine protease inhibitors with improved potency: studies on inhibition mechanism. Vicik R; Helten H; Schirmeister T; Engels B ChemMedChem; 2006 Sep; 1(9):1021-8. PubMed ID: 16933238 [TBL] [Abstract][Full Text] [Related]
10. Peptidyl epoxides extended in the P' direction as cysteine protease inhibitors: effect on affinity and mechanism of inhibition. Perlman N; Hazan M; Shokhen M; Albeck A Bioorg Med Chem; 2008 Oct; 16(19):9032-9. PubMed ID: 18789705 [TBL] [Abstract][Full Text] [Related]
11. Synthesis and biological evaluation of reversible inhibitors of IdeS, a bacterial cysteine protease and virulence determinant. Berggren K; Johansson B; Fex T; Kihlberg J; Björck L; Luthman K Bioorg Med Chem; 2009 May; 17(9):3463-70. PubMed ID: 19362485 [TBL] [Abstract][Full Text] [Related]
12. Theoretical study on the mechanism of a ring-opening reaction of oxirane by the active-site aspartic dyad of HIV-1 protease. Kóna J Org Biomol Chem; 2008 Jan; 6(2):359-65. PubMed ID: 18175006 [TBL] [Abstract][Full Text] [Related]
13. Aza-peptide epoxides: potent and selective inhibitors of Schistosoma mansoni and pig kidney legumains (asparaginyl endopeptidases). James KE; Götz MG; Caffrey CR; Hansell E; Carter W; Barrett AJ; McKerrow JH; Powers JC Biol Chem; 2003 Dec; 384(12):1613-8. PubMed ID: 14719804 [TBL] [Abstract][Full Text] [Related]
14. Cysteine protease inhibitors containing small rings. Schirmeister T; Klockow A Mini Rev Med Chem; 2003 Sep; 3(6):585-96. PubMed ID: 12871161 [TBL] [Abstract][Full Text] [Related]
15. Cis-Configured aziridines are new pseudo-irreversible dual-mode inhibitors of Candida albicans secreted aspartic protease 2. Degel B; Staib P; Rohrer S; Scheiber J; Martina E; Büchold C; Baumann K; Morschhäuser J; Schirmeister T ChemMedChem; 2008 Feb; 3(2):302-15. PubMed ID: 18038380 [TBL] [Abstract][Full Text] [Related]
16. On the origin of the stabilization of the zwitterionic resting state of cysteine proteases: a theoretical study. Mladenovic M; Fink RF; Thiel W; Schirmeister T; Engels B J Am Chem Soc; 2008 Jul; 130(27):8696-705. PubMed ID: 18557615 [TBL] [Abstract][Full Text] [Related]
17. Novel aza peptide inhibitors and active-site probes of papain-family cysteine proteases. Verhelst SH; Witte MD; Arastu-Kapur S; Fonovic M; Bogyo M Chembiochem; 2006 Jun; 7(6):943-50. PubMed ID: 16607671 [TBL] [Abstract][Full Text] [Related]
18. Inactivation of cysteine proteases by peptidyl epoxides: characterization of the alkylation sites on the enzyme and the inactivator. Albeck A; Kliper S Biochem J; 2000 Feb; 346 Pt 1(Pt 1):71-6. PubMed ID: 10657241 [TBL] [Abstract][Full Text] [Related]
19. A quantum mechanical investigation of possible mechanisms for the nucleotidyl transfer reaction catalyzed by DNA polymerase beta. Bojin MD; Schlick T J Phys Chem B; 2007 Sep; 111(38):11244-52. PubMed ID: 17764165 [TBL] [Abstract][Full Text] [Related]
20. Dipeptidyl-alpha,beta-epoxyesters as potent irreversible inhibitors of the cysteine proteases cruzain and rhodesain. González FV; Izquierdo J; Rodríguez S; McKerrow JH; Hansell E Bioorg Med Chem Lett; 2007 Dec; 17(24):6697-700. PubMed ID: 17977725 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]